aod9604 fda approval status Peptide Reclassification 2026 From BPC-157 to TB-500 to

For researchers interested in body recomposition rather than just weight loss, these properties are particularly valuable

users often dose it lower or less often than the unmodified form

This area is often chosen because it provides a large, well-developed muscle that can accommodate the injection without causing discomfort

This product does not require to be reconstituted with bacteriostatic water

Its FDA-approved for reducing visceral adipose tissue, particularly in HIV-associated lipodystrophy, but its effects translate well for general fat loss in the abdominal region

Reconstitution: Add water slowly down the side of the vial, then gently swirl to dissolve